High-throughput functional virology for human health
Our mission is to make a positive impact on human health as virologists.
Located in New York City at the Columbia University Irving Medical Center, the Iketani Lab is focused on contributing to answering foundational basic and translational virology questions, particularly through high-throughput scalable strategies. The Lab has a strong focus on advancing new approaches that could make an impact in virology and beyond. While we focus on several viruses and specific topics, our hope is that what we develop can be broadly applicable.
Recent Lab News
Aug. 1, 2025
The Lab is awarded a grant for our COVID-19 studies from the American Lung Association - we are grateful for the support!
Jun. 30, 2025
David is off to medical school - good luck! Kevin Wang joins the Lab as a technician, welcome!
May 19, 2026
Work from the Lab on elucidating SARS-CoV-2 resistance pathways to atilotrelvir, ibuzatrelvir, and simnotrelvir is published in Nature Communications! This work identified significant cross-resistance against 3CL protease inhibitors among selected viruses, raising an important point of consideration during COVID-19 treatment, as well as highlighting the need for further compound development.